Faheem Hasnain

CIK 1352620 · President & CEO · last filed 2026-06-04

Faheem Hasnain is a President & CEO who has filed 92 SEC Form 4 insider transactions across 12 companies since 2007. The most recent filing, for KURA, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$20.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.41M

Companies

12

Total Filings

92

Lifetime Open-Market Net

-$20.89M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KURA Director 23,983 $9.05 $217.0K -$291.2K 13 2026-06-04
GOSS President & CEO 6,245,866 $0.16 $1.01M $3.22M 21 2026-03-20
Mirati Therapeutics, Inc. (MRTX) Delisted Director 10,791 $58.70 $633.4K $300.0K 8 2024-01-23
Nuvation Bio Inc. (NUVB.WS) Delisted Director 55,000 $0.01 $280 $0 1 2021-02-26
Forte Biosciences, Inc. (TOCA) Delisted Director 241,717 $1.20M 5 2019-10-04
Receptos, Inc. (RCPT) Delisted President & CEO 0 -$21.89M 5 2015-08-27
AMBIT BIOSCIENCES CORP (AMBI) Delisted Director $0.54 $0 3 2014-11-12
Pernix Sleep, Inc. (SOMX) Delisted Director 24,519 $0 7 2013-01-03
FACT President & CEO 102,667 $10.65 $1.09M $0 4 2010-04-21
PDL BIOPHARMA, INC. (PDLI) Delisted President & CEO 125,000 $0 1 2008-10-03
BIIB EVP, Oncology/Rheumatology SBU 25,454 $200.05 $5.09M -$3.43M 12 2008-07-10
TERCICA INC (TRCA) Delisted Director $7.87 $0 1 2008-02-28

Recent Filings

92 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-04 KURA Grant (A) $0 EDGAR
2026-03-20 GOSS Mixed $0 EDGAR
2026-01-05 GOSS Grant (A) +280,000 $0 EDGAR
2025-12-10 KURA Mixed -$78.6K EDGAR
2025-10-02 GOSS Grant (A) +437,500 $0 EDGAR
2025-06-06 KURA Grant (A) $0 EDGAR
2025-03-24 KURA Mixed -$38.1K EDGAR
2025-03-06 GOSS Grant (A) $0 EDGAR
2024-06-24 GOSS Buy (P) +372,000 $250.3K EDGAR
2024-06-07 KURA Grant (A) $0 EDGAR
Showing 110 of 92
Page 1 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.